Haripriya Kalluri

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

Nadine Rouphael, Michele Paine, Regina Mosley et al. · The Lancet · 2017 · 411 citations · Full text

Vaccination, Vaccine Safety, Cross-protection +11

Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects

Jaya Arya, Sébastien Henry, Haripriya Kalluri et al. · Biomaterials · 2017 · 223 citations

Medicine, Human Subjects, Dermatology +1

Formation and Closure of Microchannels in Skin Following Microporation

Haripriya Kalluri, Ajay K. Banga · Pharmaceutical Research · 2010 · 140 citations

Skin Following Microporation, Engineering, Microfabrication +5

Characterization of Microchannels Created by Metal Microneedles: Formation and Closure

Haripriya Kalluri, Chandra Sekhar Kolli, Ajay K. Banga · The AAPS Journal · 2011 · 140 citations · Full text

Metal Microneedles, Engineering, Microfabrication +6

Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature

Elena V. Vassilieva, Haripriya Kalluri, Devin V. McAllister et al. · Drug Delivery and Translational Research · 2015 · 90 citations

Vaccination, Room Temperature, Cross-protection +10